Effect of ascorbic acid on lipid profile and lipid peroxidation in hypercholesterolemic rabbits

Nutrition Research

Volumn 17, Issue 2, 1997, Pages 231-241

  Das, Sabari ^a   Snehlata, ^a   Srivastava, L M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Ascorbic acid; Cholesterol; Diet; Lipoproteins; Malondialdehyde; Peroxidation

Indexed keywords

ASCORBIC ACID; CHOLESTEROL; LIPOPROTEIN; MALONALDEHYDE;

ANIMAL MODEL; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIET THERAPY; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VITAMIN INTAKE; VITAMIN METABOLISM;

EID: 0031081572     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(96)00254-0     Document Type: Article

References (20)

1. 1. Tyroler HA. Lowering plasma cholesterol levels decreases risk of CHD: an overview of clinical trials. In: Steinberg D, olefsky JM eds. Hypercholesterolemia and atherosclerosis. New York:NY, Churchill, Livingstone. 1987;99-116.
2. 2. Goldstein JL, Brown MS. The low density lipoprotein pathway and its relationship to atherosclerosis. Annu Rev Biochem 1977;46:897-930.
3. 3. Steinberg D. Lipiproteins and atherosclerosis: a look back and alook ahead. Arteriosclerosis 1983; 3:283-301.
4. 4. Steinberg D, Witztum JL. Lipoproteins and atherogenesis. JAMA 1990; 264:3047-3052.
5. 5. Mandeep R Mehra, Carl J Lavie, Hector O Ventura, Richard V Milani. Prevention of atherosclerosis: the potential role of antioxidants. Postgrad Med 1995; 98(1):175-176.
6. 6. Wilson ED, Spiger MJ. A dual participation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J Lab & Clin Med 1973; 82:473.
7. 7. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90:37-43.
8. 8. Achtani C, Awtade A, Vasisht S, Srivastava LM. Effect of MaxEPA (fish oil) on lipoproteins and its receptors in hypercholesterolemic rabbits. Biochem. and Mol Bio Int 1995; 37:489-498.
9. 9. Myasnikov Al. Influence of some factors on development of experimental cholesterol atherosclerosis. Circulation 1958; 17:99-113.
10. 10.Nambisan B, Kurup PA. Ascorbic acid and glycosaminoglycan and lipid metabolism in guinea pigs fed normal and atherogenic diets. Atherosclerosis 1975; 22:447-461.
11. 11.JoAnn E Manson, Meir J Stampfer, Walter C Willett et al. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation 1992; 85(2):865-870.
12. 12.Catharine R Gale, Christopher N Martyn, Paul D Winter Cyrus Cooper. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Brit Med J 1995; 310:1563-1566.
13. 13.Carew TE, Koschinsky T, Hayes SR, Steinberg D. Mechanisms by which HDL slow the atherogenic process. Lancet April 3, 1976;1315-1317.
14. 14.Howard PA, Meyers DG. Effect of vitamin C on plasma lipids. Annal Pharmacother 1995; 29:1129-1136.
15. 15.Prasad K, Kalra J. Experimental atherosclerosis and oxygen free radicals. Angiology 1989; 40:835-843.
16. 16.Sharma P, Pramod J, Sharma PK, Chaturvedi SK and Kothari LK. Effect of vitamin C administration on serum and aortic lipid profile of guinea pigs. Ind J Med Res 1988; 87;283-289.
17. 17.Steinberg D, Parthasarathy S, Carew TE, Khoo JC Witztum JL. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenecity. N Engl J Med 1989; 320:915-924.
18. 18.Steinberg D. Antioxidant in the prevention of human atherosclerosis. Circulation 1992; 85:2338-2345.
19. 19.Daughterty A, Zweifel BS, Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol fed rabbits. Br J Pharmacol 1989;98:612-618.
20. 20.Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986; 77:641-644.